Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Viral Vaccines | 10 | 2020 | 7560 | 0.75 | Why? |
| Meningitis, Aseptic | 1 | 2017 | 22 | 0.70 | Why? |
| Mumps | 1 | 2017 | 110 | 0.62 | Why? |
| Vaccines | 3 | 2021 | 3692 | 0.46 | Why? |
| Vaccines, Attenuated | 3 | 2020 | 952 | 0.41 | Why? |
| Measles | 1 | 2017 | 608 | 0.40 | Why? |
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 645 | 0.38 | Why? |
| CD4 Lymphocyte Count | 2 | 2017 | 1517 | 0.23 | Why? |
| Health Information Interoperability | 1 | 2021 | 80 | 0.21 | Why? |
| Pharmacoepidemiology | 1 | 2021 | 84 | 0.21 | Why? |
| Product Surveillance, Postmarketing | 1 | 2021 | 189 | 0.18 | Why? |
| Drug Evaluation, Preclinical | 2 | 2020 | 3347 | 0.18 | Why? |
| Counselors | 1 | 2017 | 37 | 0.17 | Why? |
| Risk Assessment | 9 | 2020 | 25439 | 0.17 | Why? |
| Pharmacovigilance | 2 | 2021 | 501 | 0.17 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.16 | Why? |
| Technology | 1 | 2020 | 812 | 0.13 | Why? |
| Immunization | 2 | 2018 | 2019 | 0.13 | Why? |
| Vaccines, DNA | 1 | 2020 | 871 | 0.13 | Why? |
| Ebolavirus | 1 | 2020 | 834 | 0.13 | Why? |
| Point-of-Care Systems | 2 | 2017 | 2955 | 0.13 | Why? |
| Community Health Workers | 1 | 2017 | 468 | 0.11 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.11 | Why? |
| Purpura, Thrombocytopenic | 1 | 2008 | 12 | 0.09 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2008 | 282 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.07 | Why? |
| Kenya | 2 | 2017 | 887 | 0.07 | Why? |
| Point-of-Care Testing | 1 | 2017 | 2782 | 0.07 | Why? |
| Genetic Vectors | 2 | 2020 | 1600 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.06 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.05 | Why? |
| Pacific Islands | 1 | 2021 | 152 | 0.05 | Why? |
| Terminology as Topic | 1 | 2004 | 546 | 0.04 | Why? |
| Lost to Follow-Up | 1 | 2017 | 79 | 0.04 | Why? |
| Societies, Scientific | 1 | 2020 | 414 | 0.04 | Why? |
| International Cooperation | 2 | 2021 | 3436 | 0.04 | Why? |
| Immunization Schedule | 2 | 2018 | 1305 | 0.04 | Why? |
| Patient Safety | 2 | 2020 | 4885 | 0.04 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.03 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Immunogenicity, Vaccine | 2 | 2020 | 4624 | 0.03 | Why? |
| Asia | 1 | 2021 | 2399 | 0.03 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2018 | 694 | 0.03 | Why? |
| Government Regulation | 1 | 2020 | 842 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2020 | 1562 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Counseling | 1 | 2017 | 747 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.03 | Why? |
| Animals | 4 | 2020 | 78931 | 0.03 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2017 | 23402 | 0.03 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2020 | 3231 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Poisson Distribution | 1 | 2008 | 348 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Registries | 2 | 2018 | 12327 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| Internet | 1 | 2020 | 6204 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Sex Distribution | 1 | 2008 | 2083 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Age Distribution | 1 | 2008 | 3567 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
| Incidence | 1 | 2008 | 25622 | 0.00 | Why? |
| Cohort Studies | 1 | 2008 | 36005 | 0.00 | Why? |
| Child, Preschool | 1 | 2008 | 36283 | 0.00 | Why? |
| Male | 2 | 2017 | 367725 | 0.00 | Why? |
| Female | 2 | 2017 | 380317 | 0.00 | Why? |
| United States | 1 | 2008 | 46150 | 0.00 | Why? |
| Aged | 1 | 2017 | 215776 | 0.00 | Why? |
| Severity of Illness Index | 1 | 2008 | 48226 | 0.00 | Why? |
| Adult | 1 | 2017 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2017 | 270681 | 0.00 | Why? |
| Child | 1 | 2008 | 70012 | 0.00 | Why? |
| Retrospective Studies | 1 | 2008 | 105322 | 0.00 | Why? |
Chen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(69)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_